Pharmovital ApS: Financial statements 2022
CVR: 27206506
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Pharmovital ApS (CVR 27206506) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,524,145 and a net result of DKK 718,535 compared with DKK -772,171 the year before. That is an increase of 135.2% compared with the year before. Equity in the 2022 report amounted to DKK 2,349,313. The solvency ratio was 36.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,524,145
- Profit/Loss
- DKK 718,535
- Equity
- DKK 2,349,313
- Total Assets
- DKK 6,471,427
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.5M | 719K | 2.3M | 3 |
| 2021 | - | 1.1M | -772K | 1.9M | 3 |
| 2020 | - | 1.8M | 251K | 1.7M | 2 |
| 2019 | - | 2.3M | 807K | 1.6M | 2 |
| 2018 | - | 1.2M | -353K | 828K | 2 |
Official annual report
Keep an eye on Pharmovital ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Pharmovital ApS
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 7 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.